Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hartmann

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|April 25, 2017
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized studyHege Kampen Pihlstrøm, Franscesca Gatti, Clara Hammarström, et al.
Clinical Transplantation|March 4, 2014
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patientsZhigang Chen, Rachida Bouamar, Ron H N Van Schaik, et al.
Diabetologia|August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney aloneJørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 18, 2017
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid LevelIvar A Eide, Christina Dörje, My Svensson, et al.
Transplantation|November 30, 2005
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal functionGraeme Russ, Giuseppe Segoloni, Rainer Oberbauer, et al.
Frontiers in Immunology|July 15, 2024
Cellular immunity against cytomegalovirus and risk of infection after kidney transplantationKjersti B Blom, Grete B Kro, Karsten Midtvedt, et al.
Plos One|December 16, 2020
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipientsHege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, et al.
Transplantation|May 22, 2013
A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipientsStuart M Flechner, Alihan Gurkan, Anders Hartmann, et al.
Transplantation|May 22, 2023
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic ManagementKjersti B Blom, Grete K Birkeland, Karsten Midtvedt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 23, 2004
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationRainer Oberbauer, Giuseppe Segoloni, Josep M Campistol, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
Transplant International : Official Journal of the European Society for Organ Transplantation|April 25, 2017
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized studyHege Kampen Pihlstrøm, Franscesca Gatti, Clara Hammarström, et al.
Clinical Transplantation|March 4, 2014
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patientsZhigang Chen, Rachida Bouamar, Ron H N Van Schaik, et al.
Diabetologia|August 23, 2014
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney aloneJørn P Lindahl, Finn P Reinholt, Ivar A Eide, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|November 18, 2017
Development of Kidney Transplant Fibrosis Is Inversely Associated With Plasma Marine Fatty Acid LevelIvar A Eide, Christina Dörje, My Svensson, et al.
Transplantation|November 30, 2005
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal functionGraeme Russ, Giuseppe Segoloni, Rainer Oberbauer, et al.
Frontiers in Immunology|July 15, 2024
Cellular immunity against cytomegalovirus and risk of infection after kidney transplantationKjersti B Blom, Grete B Kro, Karsten Midtvedt, et al.
Plos One|December 16, 2020
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipientsHege Kampen Pihlstrøm, Thor Ueland, Annika E Michelsen, et al.
Transplantation|May 22, 2013
A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipientsStuart M Flechner, Alihan Gurkan, Anders Hartmann, et al.
Transplantation|May 22, 2023
Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic ManagementKjersti B Blom, Grete K Birkeland, Karsten Midtvedt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 23, 2004
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationRainer Oberbauer, Giuseppe Segoloni, Josep M Campistol, et al.
Pageof 20